PMH31 12 MONTH COST-UTILITY ANALYSIS OF ORAL ANTIPSYCHOTIC TREATMENTS IN PATIENTS WITH SCHIZOPHRENIA IN THE PAN-EUROPEAN SOHO (SCHIZOPHRENIA OUTPATIENT HEALTH OUTCOMES) STUDY
Abstract
Authors
M Knapp F Windmeijer JM Haro S Kontodimas J Brown S Tzivelekis D Novick M Ratcliffe